COMPANY
Huxley Medical
Funding and NIH signals
- SEC Form D raise Raised $11.02M in debt securities (Form D filed Sep 30, 2026); +2 other Form D filings in the last 12 months. SEC Form D 0001869701-26-000004 (Sep 30, 2026)
Evidence (3 events)
- Sep 30, 2026 · SEC Form D 0001869701-26-000004
Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D; Filing date: 2026-09-30; Industry Group: Other Health Care; Date of First Sale: 2026-09-16; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 11700000; Total Amount Sold: 11019335; Federal exemptions: 06b - Apr 27, 2026 · SEC Form D 0001869701-26-000002
Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D; Filing date: 2026-04-27; Industry Group: Other Health Care; Date of First Sale: 2026-04-17; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2774482; Federal exemptions: 06b || Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D/A; Filing date: 2026-06-12; Industry Group: Other Health Care; Date of First Sale: 2026-04-17; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 3000000; Total Amount Sold: 2999568; Federal exemptions: 06b - Nov 26, 2025 · SEC Form D 0001869701-25-000004
Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D; Filing date: 2025-11-26; Industry Group: Other Health Care; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 5904105; Federal exemptions: 06b || Name of Issuer: Huxley Medical, Inc.; CIK: 1869701; Address: Atlanta, GA; Submission type: D/A; Filing date: 2026-02-12; Industry Group: Other Health Care; Date of First Sale: 2025-11-14; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 9983145; Federal exemptions: 06b
- Sep 30, 2026 · SEC Form D 0001869701-26-000004
Timeline
- FDA FDA 510(k) clearance: SANSA HSAT — K252497, Dec 10, 2025. Applicant at approval: Huxley Medical. source ↗
- FDA FDA 510(k) clearance: SANSA HSAT — K250882, Oct 29, 2025. Applicant at approval: Huxley Medical. source ↗
- FDA FDA 510(k) clearance: SANSA HSAT — K244027, Jan 28, 2025. Applicant at approval: Huxley Medical. source ↗
- Trial start —: 12 Lead ECG Database source ↗
- Trial start —: Electrocardiogram (ECG) Validation Study source ↗
- Trial start Not phased (device or behavioral study): Polysomnography Validation of the Sansa Device source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06070389 | Polysomnography Validation of the Sansa Device | Not phased (device or behavioral study) | Completed | Jun 1, 2023 | Dec 13, 2023 (actual) |
| NCT06513637 | 12 Lead ECG Database | Not listed | Unknown status (ClinicalTrials.gov) | Jul 19, 2024 | Dec 31, 2025 (estimated) |
| NCT06414447 | Electrocardiogram (ECG) Validation Study | Not listed | Unknown status (ClinicalTrials.gov) | 2024-05 | 2024-06 (estimated) |
FDA records (last 2 years)
- FDA 510(k) clearance: SANSA HSAT — K252497, Dec 10, 2025. Applicant at approval: Huxley Medical. source ↗
- FDA 510(k) clearance: SANSA HSAT — K250882, Oct 29, 2025. Applicant at approval: Huxley Medical. source ↗
- FDA 510(k) clearance: SANSA HSAT — K244027, Jan 28, 2025. Applicant at approval: Huxley Medical. source ↗
NIH awards 1
- NIH award 1R43HL158282-01 FY2021: $256,207 awarded for that fiscal year; activity R43 (SBIR); PI TORSTRICK, BRENNAN; recipient as written: HUXLEY MEDICAL, INC., ATLANTA, GA. Non-invasive hemodynamic sensor patch for source ↗
Connect
See your connections at Huxley Medical on LinkedIn (search by name, results not checked)